Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. (2020). Cardiology and Cardiovascular Medicine, 4(6), 736-742. https://fortunejournals.org/ojs/index.php/ccm/article/view/15983